3Kitadai Y, Amioka T. Haruma K. et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas[]]. Int J Cancer, 2001, 93(5):662 - 666.
4van Trappen PO, Pepper MS. Lymphatic dissemination of tumour cell and the formation of micrometastases [I]. Lancet,Oncol,2002.3(1): 44-52.
5Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer[]]. Anticancer Res, 2001,21 (4A): 2351 - 2355.
6Ono M. Torisu H, Fukushi J, et al. Biological implications of macrophage infiltration in human tumor angiogenesis [l]. Cancer Chemother Pharmacol, 1999, 43:69-71.
7Schutyser E, Struyf S, Proost P. et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma[J].J Biol Chem, 2002, 277(27): 24584-24593.
8Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis[J]. Am J Pathol, 2002,161(3): 947-956.
